SCHEMBL9613248

SCHEMBL9613248

CCc1ccc(/C=C(\C)C(=O)O)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 2/20 0.62
TBXAS1 P24557 7/20 0.54
KMT2A Q03164 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
MEN1 O00255 1/20 0.50
MAPT P10636 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
ALDH1A1 P00352 4/20 0.48
KDM4E B2RXH2 1/20 0.42
HPGD P15428 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
PLK1 P53350 1/20 0.40
HTT P42858 1/20 0.40
ALOX5 P09917 1/20 0.40
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40
GLA P06280 1/20 0.39
POLB P06746 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21192734 1.00 AKR1C3 (0.62) AKR1C3TBXAS1KMT2ASMN1; SMN2MEN1
SCHEMBL22042864 0.95 AKR1C3 (0.56) AKR1C3TBXAS1KMT2ASMN1; SMN2MEN1
SCHEMBL23512754 0.95 AKR1C3 (0.56) AKR1C3TBXAS1KMT2ASMN1; SMN2MEN1
SCHEMBL12961218 0.86 KMT2A (0.51) AKR1C3TBXAS1KMT2ASMN1; SMN2MEN1
SCHEMBL7764222 0.86 TBXAS1 (0.68) AKR1C3TBXAS1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL7764218 0.86 TBXAS1 (0.68) AKR1C3TBXAS1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL2462984 0.85 AKR1C3 (0.82) AKR1C3TBXAS1ALDH1A1KDM4EHTT
SCHEMBL2462983 0.85 AKR1C3 (0.82) AKR1C3TBXAS1ALDH1A1KDM4EHTT
SCHEMBL1410816 0.85 AKR1C3 (0.62) AKR1C3TBXAS1SMN1; SMN2ALDH1A1NPC1
SCHEMBL1410819 0.85 AKR1C3 (0.62) AKR1C3TBXAS1SMN1; SMN2ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1727797-B1 PROCESS FOR CROSS COUPLING INDOLES BOEHRINGER INGELHEIM PHARMA (US) 2012-05-30 EP disclosed
EP-1414797-B9 HEPATITIS C VIRUS POLYMERASE INHIBITORS WITH A HETEROBICYLIC STRUCTURE BOEHRINGER INGELHEIM CA LTD (CA) 2009-04-15 EP disclosed
EP-1414797-B1 HEPATITIS C VIRUS POLYMERASE INHIBITORS WITH A HETEROBICYLIC STRUCTURE BOEHRINGER INGELHEIM CA LTD (CA) 2008-01-02 EP disclosed